Introduction
Surgical site infections (SSIs) are largely preventable, but they represent a considerable burden for health-care systems, particularly in low-income and middle-income countries. For these reasons, and the fact that no general set of international recommendations exists, WHO prioritised the development of evidence-based global guidelines for the prevention of SSIs. A panel of international experts developed recommendations on the basis of predetermined research questions and the results of related systematic literature reviews. The description of the intended audience for these recommendations, the methods used, and the fi rst group of recommendations regarding preoperative preventive measures are provided in paper 1 of this Series, 1 which should be read in conjunction with this Review. We present here the recommendations (table) to be applied in the intraoperative and postoperative periods. Important topics such as asepsis in the operating room and sterilisation are not mentioned because they were not the object of formal recommendations, but they are included and extensively reviewed in the WHO guidelines, as cornerstones of SSI prevention.
Recommendation 1: perioperative oxygenation

The panel recommends that adult patients undergoing general anaesthesia with endotracheal intubation for surgical procedures should receive an 80% fraction of inspired oxygen (FiO 2 ) intraoperatively and, if feasible, in the immediate postoperative period for 2-6 h, to reduce the risk of SSI (strong recommendation, moderate quality of evidence).
Adequate surgical site tissue oxygenation is thought to have a role in preventing SSIs. A high partial pressure of oxygen in the blood achieved through the administration of high-concentration oxygen (hyperoxia, defi ned as oxygen at 80% FiO 2 ) provides more adequate oxygenation at the surgical incision-particularly at infected tissue, 4 which has a lower oxygen tension than non-infected tissue 5 -and might enhance oxidative killing by neutrophils. 6 We did a systematic review to assess the eff ect of high FiO 2 (80%) compared with standard FiO 2 (30-35%) for the prevention of SSI.
We identifi ed 15 randomised controlled trials (RCTs) [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] comparing the perioperative administration of 80% FiO 2 with 30-35% FiO 2 in adults. We did a meta-analysis that included studies in which patients underwent general anaesthesia with endo tracheal intubation and mechanical ventilation. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Ventilation control (and therefore the actual administration of FiO 2 ) with a facemask or nasal cannulae in neuraxial anaesthesia was considered to be a diff erent intervention from mechanical ventilation. Furthermore, a meta-regression analysis showed that the type of anaesthesia independently modifi ed the eff ect of hyperoxygenation. The 11 RCTs included in the meta-analysis showed that increased perioperative FiO 2 is benefi cial in reducing SSI compared with standard perioperative FiO 2 (odds ratio [OR] 0·72; 95% CI 0·55-0·94). The quality of the evidence was rated as moderate.
On the basis of this evidence, patients undergoing general anaesthesia with endotracheal intubation for surgical procedures should receive 80% FiO 2 intraoperatively and, if feasible, for 2-6 h in the immediate postoperative period. The expert panel noted that the benefi ts of this intervention can be observed only when implemented by both intubation during the operation, and using a high-fl ux mask in the immediate postoperative period (fi gure). The benefi ts are also Series maximised when normothermia and normovolaemia are maintained. In low-resource settings in which medical oxygen is scarce and its increased use could place a burden on available resources, this recommendation might not be considered as a priority by policymakers.
Recommendation 2: maintaining normal body temperature (normothermia)
The panel suggests the use of warming devices in the operating room and during the surgical procedure for patient body warming with the purpose of reducing SSI (conditional recommendation, moderate quality of evidence).
Hypothermia is defi ned as a core temperature less than 36°C. It commonly occurs during and after surgical procedures lasting more than 2 h because of impairment of thermoregulation by anaesthesia, combined with exposure to a cold environment (the operating room). 22, 23 Unintended hypothermia is considered to be an adverse event of general and regional anaesthesia and might be associated with increased cardiac complications, blood loss due to impaired coagulation, impaired wound healing, decreased drug metabolism, decreased immune function, and an increased risk of SSI. 22, [24] [25] [26] [27] We did a systematic review to assess the eff ectiveness of perioperative body warming on the prevention of SSIs.
We found two RCTs 28, 29 comparing the eff ect of preoperative and intraoperative body warming on SSIs in adults with no body warming. Meta-analysis showed that body warming was signifi cantly associated with a reduced risk of SSIs (OR 0·33; 95% CI 0·17-0·62); the quality of the evidence was rated as moderate. However, in developing A rise in blood glucose concentration is commonly observed in the operative and postoperative periods because of a surgical stress response, resulting in increased secretion of catabolic hormones (eg, catecholamines or cortisol), inhibition of insulin secretion, and insulin resistance. 30 Observational studies have shown that hyperglycaemia is associated with an increased risk of SSIs in both diabetic and non-diabetic patients. [31] [32] [33] Although the importance of perioperative blood glucose control is agreed upon, there is controversy regarding the best treatment options, the optimal target concentration of blood glucose, and the optimal timing of glucose control. The concern is due to the risk of developing hypoglycaemia, which is also associated with increased morbidity and mortality. [34] [35] [36] [37] We did a systematic review to investigate whether the In particular for the construction of future health-care facilities, this recommendation will reduce costs (13) Antimicrobial prophylaxis in the presence of a drain
In the presence of drains, does prolonged antibiotic prophylaxis prevent SSI?
Perioperative surgical antibiotic prophylaxis should not be continued because of the presence of a wound drain for the purpose of preventing SSI
Conditional recommendation (low)
This recommendation leads to a cost reduction because of reduced antibiotic use; it also contributes to preventing antimicrobial resistance (14) Optimal timing for wound drain removal When using drains, how long should they be kept in place to minimise SSI as a complication?
The wound drain should be removed when clinically indicated; no evidence was found to make a recommendation on the optimal exact timing
Conditional recommendation (very low)
This recommendation has the potential to reduce costs because of a shortened hospital stay as a result of early drain removal This recommendation leads to a cost reduction because of reduced antibiotic use; it also contributes to preventing antimicrobial resistance SSI=surgical site infection. *WHO recommendations for preoperative measures are included in paper 1 1 of this surgical site infections Series, to be read in combination with this Review. †The Grading of Recommendations Assessment, Development, and Evaluation method 2,3 was used to assess the quality of the retrieved evidence. ‡We could not assess separately the use of sterile disposable non-woven vs sterile reusable woven drapes and sterile disposable non-woven vs sterile reusable woven gowns, because no specifi c evidence was retrieved. §We could not assess saline irrigation of incisional wounds before closure, because insuffi cient evidence was found. ¶We could not assess the use of fans or cooling devices vs conventional operating room ventilation, or whether natural ventilation an acceptable alternative to conventional ventilation, because insufficient evidence was retrieved. Overall, an intensive protocol with strict blood glucose target concentrations was associated with signifi cantly decreased SSI incidence compared with a conventional protocol (OR 0·43; 95% CI 0·29-0·64). Because of the heterogeneity of the timing of application of the protocols (intraoperative vs intraoperative-and-postoperative vs postoperative), study population (patients with diabetes vs patients without diabetes vs mixed population), and the upper limit of the target concentration of blood glucose (≤110 mg/dL [6·1 mmol/L] vs 110-150 mg/dL [6·1-8·3 mmol/L]), we decided to do separate metaanalyses for each of these comparisons. No signifi cant diff erence in the eff ect on SSI reduction was observed between studies of patients with and without diabetes in meta-regression analyses (p=0·590). There was some evidence that the SSI reduction eff ect was smaller in studies that used intensive blood glucose control intraoperatively only (OR 0·88; 0·45-1·74) compared with studies that used intensive blood glucose controls postoperatively or both intra operatively and postoperatively (OR 0·37; 0·25-0·55; p=0·049 for diff erence between these ORs).
No signifi cant diff erence was observed (p=0·328) between studies that used low upper limit target blood glucose concentrations (≤110 mg/dL; 6·1 mmol/L), versus studies with high upper limit concentrations (110-150 mg/dL; 6·1-8·3 mmol/L). The overall quality of the evidence was rated as low. Further analysis of adverse events showed no diff erence between the use of an intensive protocol and a conventional protocol in the risk of death (OR 0·74; 95% CI 0·45-1·23; p=0·2) or stroke (OR 1·37; 0·26-7·20; p=0·7). However, there was an overall increased risk of hypoglycaemia (OR 5·55; 2·58-11·96). Meta-regression analyses showed no diff erence in the risk of hypoglycaemia between studies that used low or high upper limit target blood glucose concentrations (p=0·413).
In conclusion, using a protocol with strict blood glucose target concentrations is associated with a substantial benefi t for the reduction of SSI prevalence, but neither the optimal blood glucose target concentration nor the perioperative timing of glucose control could be defi ned. However, it should be noted that hypoglycaemia is a possible serious side-eff ect associated with these intensive protocols and close reliable monitoring of blood glucose concentrations is crucial for this intervention.
Recommendation 4: maintenance of adequate circulating volume control (normovolaemia)
The panel suggests the use of goal-directed fl uid therapy (GDFT) intraoperatively to reduce the risk of SSI (conditional recommendation, low quality of evidence).
Adequate intravascular volume is an essential component of tissue perfusion and an important aspect of tissue oxygenation. 53 In unbalanced fl uid states-ie, hypovolaemia and hypervolaemia-tissue oxygenation is compromised and might increase the risk of SSI. 54 The optimal type of fl uid (colloid or crystalloid) or strategy of fl uid management (goaldirected, liberal, or restrictive) remain controversial topics, partly because of the absence of a universal defi nition of normovolaemia or a standardised method for its assessment. We did a systematic review to assess whether specifi c fl uid management strategies for the maintenance of normovolaemia are more eff ective in reducing the risk of SSI than standard fl uid regimens administered during surgery.
We identifi ed 24 RCTs 55-78 comparing specifi c strategies of fl uid management with standard management. Because of substantial heterogeneity in the type of specifi c fl uid management strategy used, separate meta-analyses were done for GDFT or restrictive fl uid regimens versus standard regimens in the preoperative, intraoperative, and postoperative periods. GDFT refers to a haemo dynamic treatment based on the titration of fl uid and inotropic drugs according to cardiac output or similar parameters. Restrictive fl uid management refers to the administration of a regimen with a reduced volume Series of fl uids in the bolus or over time, compared with local standard fl uid maintenance. A meta-analysis of 14 RCTs [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] showed that intraoperative GDFT was signifi cantly associated with lower incidence of SSIs than standard intraoperative fl uid management (OR 0·56; 95% CI 0·35-0·88). Meta-analysis of fi ve RCTs [69] [70] [71] [72] [73] showed that restrictive intraoperative fl uid management did not signifi cantly aff ect SSI incidence compared with standard intraoperative management (OR 0·73; 0·41-1·28). Meta-analysis of two RCTs 76, 77 showed that postoperative GDFT was associated with a decreased risk of SSI compared with standard postoperative management (OR 0·24; 0·11-0·52). One RCT 74 showed that preoperative GDFT did not signifi cantly aff ect SSI incidence compared with standard preoperative management (OR 0·47; 0·13-1·72).
Considering the evidence (rated as low quality), the panel suggested the use of GDFT intraoperatively to prevent SSI. Its postoperative use might also be benefi cial to reduce SSI. However, restrictive fl uid management and preoperative GDFT were not associated with the reduction of SSI compared with standard fl uid management. Drapes and gowns are available for single-use or multiple-use, with varying compositions. Adhesive plastic incise drapes are used on a patient's skin after surgical site preparation, with or without antimicrobial impregnation, and the surgeon performs the incision of the drape and the skin simultaneously. In available guidelines, there are confl icting recommendations on the use of plastic adhesive drapes, mainly discouraging their use. 79 There are no recommendations on the use of single-use or reusable drapes and gowns for the purpose of SSI prevention. We did a systematic review to investigate the use of sterile disposable or reusable drapes and surgical gowns, and separately the use of plastic adhesive incise drapes, for the purpose of SSI prevention.
Recommendations 5 and 6: drapes and gowns
We identifi ed 11 studies [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] (four RCTs 81, 86, 89, 90 ). Meta-analysis of fi ve studies (one RCT, 81 one quasi-RCT, 82 and three observational studies 80, 83, 84 ) comparing sterile disposable non-woven drapes and gowns with sterile reusable woven drapes and gowns showed no diff erence in the SSI risk (RCTs, moderate quality evidence: OR 0·85; 95% CI 0·66-1·09; observational studies, very low quality evidence: OR 1·56; 0·89-2·72). Meta-analysis of four studies (one RCT, 86 one quasi-RCT, 85 and two observational studies 87, 88 ) comparing adhesive iodine-impregnated incise drapes with no drapes showed no diff erence in the SSI risk (RCTs: OR 2·62; 0·68-10·04; observational studies: OR 0·49; 0·16-1·49). Similarly, meta-analysis of two RCTs 89,90 comparing non-impregnated adhesive incise drapes to no drapes showed no diff erence in the SSI risk (OR 1·10; 0·68-1·78). The quality of the evidence was rated low to very low.
Considering the evidence, including potential issues of availability and costs in low-resource settings and the ecological eff ect, the expert panel suggested that either sterile disposable non-woven or sterile reusable woven drapes and gowns can be used. However, adhesive incise drapes (with or without antimicrobial properties) should not be used for the purpose of preventing SSI.
Recommendation 7: wound-protector devices
The panel suggests considering the use of wound-protector devices in clean-contaminated, contaminated, and dirty abdominal surgical procedures for the purpose of reducing the rate of SSIs (conditional recommendation, very low quality of evidence).
Wound-protector devices (or wound-edge protectors) are comprised of a non-adhesive plastic sheath attached to a single or double rubber ring that fi rmly secures the sheath to the wound edges. They facilitate the retraction of the incision during surgery and are aimed at reducing wound-edge contamination to a minimum during abdominal surgical procedures. Notably, they have been on the market despite scarce evidence supporting their usefulness. We did a systematic review to assess the eff ectiveness of wound-protector devices for the reduction of SSI risk compared with conventional wound protection in abdominal surgery.
We found 11 studies (ten RCTs, 91-100 and one prospective controlled trial 101 ) in adults. Meta-analysis showed that the use of a wound-protector device (single-ring or double-ring) was associated with a signifi cantly lower risk of SSI than with conventional wound protection (OR 0·42; 95% CI 0·28-0·62). Meta-regression analyses showed no evidence of a diff erence in the eff ect between single-ring and double-ring wound-protector devices or between clean-contaminated, contaminated, or dirty surgery and other surgery.
Considering the evidence (rated as very low quality), the panel suggests the use of wound-protector devices in clean-contaminated, contaminated, and dirty abdominal surgical procedures for the prevention of SSI. The panel highlighted that wound-protector device use should not always be prioritised in low-resource settings over other interventions that prevent SSI, because of their scarce availability and associated costs. Intraoperative wound irrigation refers to the fl ow of a solution across the surface of an open wound. It is a widely practised procedure and considered to help prevent SSIs. [102] [103] [104] Among other benefi ts, wound irrigation is intended to physically remove cellular debris, surface bacteria, and body fl uids, to dilute possible contamination, and to function as a local antibacterial agent when an antiseptic or antibiotic agent is used. Practices vary depending on the patient population, the surface of application, and solutions used. We did a systematic review to investigate whether intraoperative wound irrigation (with or without active agents or pressured application) aff ects the incidence of SSI. Studies investigating the topical application of antibiotics or antiseptics (eg, powder, gels, sponges) were not included. We also excluded studies in which surgical antibiotic prophylaxis was not administered appropriately (ie, preoperatively and intravenous) or wound irrigation represented a therapeutic intervention for a pre-existent infection rather than a prophylactic measure.
Recommendations 8 and 9: incisional wound irrigation
We identifi ed 21 RCTs comparing wound irrigation with no wound irrigation in patients undergoing various surgical procedures, and the results were substantially heterogeneous. The panel decided to restrict the recommendation to incisional wound irrigation, because too little (and heterogeneous) evidence was available to address other applications of irrigation-ie, intraperitoneal or mediastinal irrigation.
Moderate to very low quality evidence from four studies using irrigation with a saline solution administered with diff erent methods provided confl icting results. 110, 113, 115, 117 Irrigation with saline solution using pulse pressure or applied with force had a marked benefi t in terms of SSI reduction. 110, 115, 117 A meta-analysis of seven RCTs 105-108 showed a signifi cant benefi t of irrigation of the incisional wound with aqueous povidone-iodine solutions in diff erent concentrations compared with irrigation with a saline solution (OR 0·31; 95% CI 0 13-0·73; p=0·007). Further stratifi cation according to the wound contamination class and povidone-iodine solution showed that the eff ect was attributable to incisional wound irrigation in clean and clean-contaminated procedures with povidone-iodine 10% and povidone-iodine 0·35%. A meta-analysis of fi ve studies [119] [120] [121] 123, 124 showed no signifi cant diff erence between antibiotic irrigation of the incisional wound and no irrigation or irrigation with a saline solution (OR 1·16; 0·64-2·12; p=0·63).
The panel concluded that the evidence was insuffi cient to recommend for or against saline irrigation of incisional wounds for the purpose of preventing SSIs.
By contrast, incisional wound irrigation with an aqueous povidone-iodine solution might have a benefi t, particularly in clean and clean-contaminated wounds. Finally, antibiotic incisional wound irrigation before closure should not be used for the purpose of preventing SSI. The expert panel strongly emphasised that this practice is associated with an unnecessary risk of antimicrobial resistance.
Allergic reactions and metabolic adverse events should be considered as potential harms of iodine uptake. Although the panel recognises that saline and povidoneiodine solutions are readily available in most settings, sterile products might be scarce in low-income and middle-income countries. In many settings, the availability and costs of pulse-pressure devices represent a high fi nancial burden, including not only their purchase, but also waste disposal, procurement, energy, and machine maintenance.
Recommendation 10: prophylactic negative-pressure wound therapy
The panel suggests the use of prophylactic negative-pressure wound therapy (pNPWT) on primarily closed surgical incisions in high-risk wounds, for the purpose of preventing SSI, while taking resources into account (conditional recommendation, low quality of evidence).
pNPWT consists of a closed sealed system connected to a vacuum pump, which maintains negative pressure on the wound surface. Although used for several other purposes since the late 1990s, it is also applied on primarily closed surgical incisions to prevent SSIs. We did a systematic review to establish whether the use of pNPWT is more eff ective in reducing the risk of SSIs than the use of conventional wound dressings.
We identifi ed 19 publications describing 20 studies (six RCTs [126] [127] [128] [129] [130] and 14 observational studies [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] ). Overall, meta-analyses of RCTs and observational studies showed that pNPWT has a signifi cant benefi t in reducing the risk of SSI in patients with a primarily closed surgical incision compared with conventional postoperative wound dressings (RCTs: OR 0·56; 95% CI 0·32-0·96; observational studies: OR 0·30; 0·22-0·42). When stratifi ed by type of surgery, this eff ect was observed in abdominal (nine observational studies; [132] [133] [134] [135] [136] 140, 141, 143, 144 OR 0·31; 0·19-0·49) and cardiac (two observational studies; 137, 138 OR 0·29; 0·12-0·69) surgery, but it was not statistically signifi cant in orthopaedic or trauma surgery. Stratifi cation by wound contamination class showed a signifi cant benefi t in reducing SSI prevalence with the use of pNPWT in clean surgery (eight observational studies; 131, 135, [137] [138] [139] 141, 142, 144 OR 0·27; 95% CI 0·17-0·42) and in clean-contaminated surgery (eight observational studies; [132] [133] [134] 136, 140, 141, 143, 144 OR 0·29; 0·17-0·50). On the basis of the low-quality evidence available, the panel suggests the use of pNPWT on primarily closed surgical incisions in high-risk conditions (eg, poor tissue perfusion due to surrounding soft tissue or skin Series damage, decreased blood fl ow, bleeding or haematoma, dead space, or intraoperative contamination) for the purpose of the prevention of SSIs, taking available resources into account. The panel highlighted that the use of pNPWT might not be prioritised in low-resource settings compared with other interventions to prevent SSI considering its poor availability and potential associated costs.
Recommendation 11: antimicrobial-coated sutures
The panel suggests the use of triclosan-coated sutures to reduce the risk of SSIs, independent of the type of surgery (conditional recommendation, moderate quality of evidence).
Sutures with antimicrobial properties were developed with the aim to prevent microbial colonisation of the suture material in operative incisions. Early studies showed a reduction of the number of bacteria in vitro and wound infections in animals [145] [146] [147] using triclosancoated sutures and this eff ect was subsequently confi rmed in clinical studies. Several novel antimicrobial coatings are now available, but still no clinical studies have been done that compare the effi cacy with noncoated sutures. 148, 149 We did a systematic review to assess whether the use of antimicrobial-coated sutures is more eff ective in reducing the risk of SSIs than the use of non-coated sutures.
We found 18 studies (13 RCTs 150-162 and fi ve cohort studies [163] [164] [165] [166] [167] ). All studies investigated triclosan-coated sutures and focused on adult patients, apart from one 152 done in a paediatric population. The overall meta-analysis showed that antimicrobial-coated sutures have a signifi cant benefi t in reducing SSI incidence in patients undergoing surgical procedures compared with noncoated sutures (RCTs: OR 0·72; 95% CI 0·59-0·88; observational studies: OR 0·58; 0·40-0·83). When considering specifi c types of sutures, only the metaanalyses of the studies comparing triclosan-coated polyglactin 910 suture with polyglactin 910 suture featuring a braided suture construction showed that the use of antimicrobial-coated sutures signifi cantly reduces SSI prevalence compared with the non-coated sutures (OR 0·62; 0·44-0·88 for RCTs; OR 0·58; 0·37-0·92 for observational studies). In meta-regression analysis, we found no evidence that the eff ect of antimicrobial coating of sutures diff ered between braided and monofi lament sutures (p=0·380), or between clean (p=0·690), cardiac (p=0·900), or abdominal (p=0·832) surgeries and other surgical procedures.
We highlighted that the quality of the evidence was moderate to low and that many studies had several limitations, including industry sponsorship or confl icts of interest with a commercial entity. On the basis of the evidence but also considering these limitations, the panel suggests the use of antimicrobial-coated sutures for the purpose of reducing the risk of SSI. Because the eff ect appears to be independent of the type of procedure or wound contamination classifi cation, this recommendation applies to any type of surgery. Availability and costs should be considered in lowincome and middle-income countries. Further studies are needed also on sutures coated with an alternative antimicrobial agent to triclosan.
Recommendation 12: laminar airfl ow ventilation systems in the context of operating room ventilation
The panel suggests that laminar airfl ow ventilation systems should not be used to reduce the risk of SSIs for patients undergoing total arthroplasty surgery (conditional recommendation, low to very low quality of evidence).
Conventional ventilation systems pass air with a mixed or turbulent fl ow into the operating room. These systems aim to homogenise the fresh air, the air, and aerosols and particles within the room. Laminar airfl ow systems pass the fresh air unidirectionally with a steady velocity and approximately parallel streamlines to create a zone in which the air, aerosols, and particles within the room are driven out. Systems with laminar airfl ow are frequently used in an environment where contamination with particles is a serious adverse event-eg, orthopaedic implant surgery. However, laminar airfl ow systems are complex and expensive and require careful maintenance. In many settings in low-income countries, neither conventional nor laminar fl ow systems are aff ordable or maintained eff ectively on a regular basis and often, natural ventilation is the only option.
We did a systematic review to assess whether a laminar airfl ow ventilation system is more eff ective in reducing the risk of SSI than a conventional ventilation system. We also investigated whether fans or cooling devices and natural ventilation are acceptable alternatives to conventional ventilation for the prevention of SSI. We only identifi ed one observational study 168 that compared natural ventilation with conventional ventilation in the operating room. No diff erence was observed in the risk of SSI following both total hip and knee arthroplasty. One systematic review 169 and eight observational studies 168, [170] [171] [172] [173] [174] [175] [176] comparing laminar airfl ow with con ventional ventil ation were identifi ed. Most studies focused on total hip and knee arthroplasty and only a few single studies were available for other types of surgery. 170, 171, 173 Meta-analyses showed that laminar airfl ow ventilation has no benefi t compared with conventional ventilation in reducing the SSI incidence in total hip (OR 1·29; 95% CI 0·98-1·71) or knee (OR 1·08; 0·77-1·52) arthroplasty. The quality of the evidence was rated as very low. Considering these results and associated costs, the expert panel decided to suggest that laminar airfl ow ventilation systems should not be used as a preventive measure to reduce the risk of SSI in patients undergoing total arthroplasty surgery.
Series
Recommendations 13 and 14: antimicrobial prophylaxis in the presence of a drain and optimal timing for wound drain removal
The panel suggests not continuing perioperative antibiotic prophylaxis because of the presence of a wound drain (conditional recommendation, low quality of evidence). They also suggest removing the wound drain when clinically indicated, but they found no evidence to recommend an optimal time for wound drain removal (conditional recommendation, very low quality of evidence).
Drainage tubes are widely used in surgery to remove any fl uid or blood that collects in the wounds and cavities created by the surgical procedure and thus might cause complications. However, drains might adversely aff ect surgical outcomes-eg, aff ecting anastomotic healing by causing infection in the anastomotic area and the abdominal wound. Many systematic reviews investigating the eff ect of drains on the related infection risk compared with no wound drainage have been published with confl icting results. The optimal time for drain removal after surgery might infl uence this risk, but it remains unknown. Furthermore, in most cases, antibiotic prophylaxis is continued postoperatively when a drain is used, but this practice is not evidence-based and raises serious concerns in terms of contributing to the emergence of antimicrobial resistance. We did a systematic review to investigate whether prolonged antibiotic prophylaxis in the presence of a wound drain is more eff ective in reducing the risk of SSIs than standard perioperative prophylaxis alone. The review also assessed whether the early removal of wound drains more eff ectively prevents SSIs than late removal.
Regarding the fi rst question, seven RCTs 177-183 were identifi ed. The meta-analysis showed that prolonged antibiotic prophylaxis in the presence of a wound drain has no benefi t in reducing SSI compared with perioperative prophylaxis alone (OR 0·79; 95% CI 0·53-1·20). We identifi ed 11 RCTs [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] comparing early with late removal of closed wound drains. However, there was heterogeneity in the study defi nitions for early and late drain removal. For the purposes of the analysis, early removal was considered to be from postoperative day 1 to day 5. Two main groups were identifi ed for defi ning late wound drain removal-ie, drain removal at postoperative day 6 or later (three studies 187, 189, 192 ) and removal on the basis of drainage volume (six studies [184] [185] [186] [187] 188, 190, 191 ). Studies not falling into these categories were excluded from the analysis. The meta-analysis showed that early drain removal does not aff ect SSI incidence compared with late removal (OR 0·86; 0·49-1·50).
On the basis of this low to very low quality evidence, the panel suggests that antibiotic prophylaxis should not be continued in the presence of a wound drain for the purpose of preventing SSI. Given the results and very low quality of the evidence about optimal timing for removal, wound drains should be removed when clinically indicated.
Recommendation 15: wound dressings
The panel suggests not using any type of advanced dressing over a standard dressing on primarily closed surgical wounds for the purpose of preventing SSIs (conditional recommendation, low quality of evidence).
A wide variety of wound dressings are available. Advanced dressings are mainly hydrocolloid, hydrogels, fi brous hydrocolloid, or polyurethane matrix hydrocolloid dressings and vapour-permeable fi lms. A Cochrane review 195 and its update 196 on the eff ect of dressings for the prevention of SSI found no evidence to suggest that one dressing type was better than any other. We did a systematic review to assess whether the use of advanced dressings is more eff ective in reducing the risk of SSIs than standard wound dressings.
We identifi ed ten RCTs [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] in adult patients undergoing various types of surgical procedures. There were variations in the defi nition of SSIs, the duration of postoperative follow-up, and in the type of dressing (hydrocolloid, hydroactive and silver-impregnated, or polyhexamethalene biguanide-impregnated dressings). Overall, the meta-analysis showed that advanced dressings do not signifi cantly reduce SSI occurrence compared with standard dressings (OR 0·80; 95% CI 0·52-1·23); the quality of the evidence was rated as low. In specifi c meta-analyses, hydrocolloid, silverimpregnated, and hydroactive dressings were non-eff ective in reducing the risk of SSI compared with standard dressings. On the basis of the evidence, the panel recommended that advanced dressings should not be used for the prevention of SSIs.
Recommendation 16: postoperative surgical antibiotic prophylaxis prolongation
The panel recommends against the prolongation of surgical antibiotic prophylaxis (SAP) administration after completion of the operation for the purpose of preventing SSIs (strong recommendation, moderate quality of evidence).
The preventive eff ect of the routine use of SAP has long been recognised; however, the necessary duration of SAP to achieve the desired eff ect has been a matter of debate. Most guidelines recommend a maximum postoperative SAP duration of 24 h, but increasing evidence shows that using only a single preoperative dose (and possible additional intraoperative doses according to the duration of the operation) might be non-inferior. Despite this, surgeons still often routinely continue SAP up to several days after surgery, which leads to serious concerns for the risk of antimicrobial resistance. We did a systematic review to investigate whether prolonged SAP in the postoperative period is more eff ective in reducing the risk of SSIs than perioperative prophylaxis (defi ned as a single dose before incision and possible intraoperative additional dose [s] according to the duration of the operation).
We found 69 RCTs 177-180,183,207-270 investigating the optimal duration of antibiotic prophylaxis in a variety of surgical Series procedures. The overall meta-analysis, which pooled studies using any prolonged SAP regimens, showed no benefi t in terms of reducing the SSI incidence compared with a single dose of antibiotic prophylaxis (OR 0·89; 95% CI 0·77-1·03). However, a meta-analysis of studies showed that SAP continuation might be benefi cial in reducing SSI compared with a single prophylactic dose in cardiac (OR 0·43; 0·25-0·76) 232, 233 and orthognathic (OR 0·30; 0·10-0·88) [242] [243] [244] surgery. Considering the low quality of the evidence and the results of the overall meta-analysis (moderate quality), the expert panel decided to strongly recommend against SAP prolongation, also because of the widespread risk of antimicrobial resistance. Continuing antibiotic administration in cardiac and orthognathic surgery has potential benefi t, but further well designed RCTs on this topic are needed.
Conclusion
We discuss the evidence for a broad range of intraoperative and postoperative preventive measures identifi ed by an expert panel as potentially contributing to reducing the risk of SSI. For some of these, the evidence shows no benefi t and the panel advises against the adoption of these interventions, particularly when considering resource implications or other consequences, such as antimicrobial resistance. However, the panel identifi ed a range of key measures for SSI prevention to be implemented in the intraoperative and postoperative periods, together with other preoperative measures discussed in paper 1 of this Series. Adoption of the recommendations should be facilitated by sound implementation strategies and practical tools. Notably, careful assessment of feasibility and cost implications in low-resource settings is needed.
